Altana Acquires Dutch Polymer Additive Maker Addcomp
News Jul 05, 2016
Specialty chemicals group ALTANA has acquired the Dutch enterprise Addcomp Holland BV. Addcomp will be integrated into the Plastic Additives business line of ALTANA’s largest division BYK Additives & Instruments. “In acquiring Addcomp, we are continuing to systematically pursue the ALTANA strategy of generating value-creating growth through targeted acquisitions,” says Dr. Christoph Schlünken, Member of the ALTANA Management Board.
“We’re pleased that with BYK we have found a new owner for Addcomp that can integrate the company’s business in a larger and more globally orientated structure to tap its full potential on the market for plastic additives,” declares Rudi Muis, Managing Director of Addcomp Holland BV.
Additives from Addcomp enhance functional performance of nearly every type of thermoplastic material for various applications like automotive, construction, packaging, etc.
“The acquisition is an ideal fit for BYK. The combination of BYK’s chemical and product expertise together with Addcomp’s unique process technology will enable us to develop and manufacture new and differentiating additives for the Thermoplastic market,” states Dr. Stephan Glander, President of BYK Additives & Instruments. “Through this acquisition we are systematically expanding our product portfolio and our application spectrum in the field of plastic additives.”
The acquisition adds a broad range of additive solutions with different functionalities, such as antifogging, improved processing, flame retardancy, heat stabilization and UV stabilization to BYK’s portfolio. Addcomp is a leader in applying masterbatch technology to achieve superb dispersion, to simplify handling of such difficult additives as liquids and viscous materials, and to provide the highest additive concentrations.
The company, headquartered in Nijverdal, the Netherlands, employs 45 persons and operates production facilities and sales offices in Nijverdal and in Rochester Hills, Michigan, USA. In the 2015 fiscal year Addcomp’s sales amounted to a double digit million Euro figure.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE